In contrast, we showed that myeloid FoxO1 deficiency protected mice from developing diet-induced inflammation and insulin resistance, a beneficial effect that halted the progression of NAFL to NASH in MøFoxO1-KO mice on a NASH diet. This evidence concerns the gene FOXO1 and non-alcoholic fatty liver.